ESMO 2024: Prof. Sibylle Loibl Discusses PENELOPE-B Trial Results

Watch as Prof. Sibylle Loibl, PI of the PENELOPE-B trial, presents the final overall survival and subgroup analyses for lobular breast cancer patients at ESMO 2024. Gain a detailed overview of the study's key findings and implications.